organo - ORGJF

ORGJF

Close Chg Chg %
57.22 -4.19 -7.32%

Closed Market

53.03

-4.19 (7.32%)

Volume: 1.10K

Last Updated:

Feb 5, 2025, 10:25 AM EDT

Company Overview: organo - ORGJF

ORGJF Key Data

Open

$52.94

Day Range

52.94 - 53.03

52 Week Range

52.94 - 53.03

Market Cap

$2.87B

Shares Outstanding

45.98M

Public Float

24.88M

Beta

1.24

Rev. Per Employee

N/A

P/E Ratio

15.59

EPS

$4.00

Yield

197.04%

Dividend

$0.60

EX-DIVIDEND DATE

Mar 30, 2026

SHORT INTEREST

N/A

AVERAGE VOLUME

30.10

 

ORGJF Performance

No Data Available

ORGJF Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings
Full Ratings ➔

About organo - ORGJF

Organo Corp. engages in the manufacture and sale of water purifiers and electrical equipment. It operates through the Water Treatment Engineering and Functional Products segments. The Water Treatment Engineering segment manufactures and sells large-scale water treatment equipment; and provides remodeling, replacement, and maintenance services. The Functional Products segment offers standard water treatment equipment, water treatment chemicals, and food additives. The company was founded on May 1, 1946 and is headquartered in Tokyo, Japan.

ORGJF At a Glance

Organo Corp.
1-2-8 Shinsuna
Tokyo, Tokyo 136-8631
Phone 81-3-5635-5100 Revenue 1.07B
Industry Industrial Machinery Net Income 158.41M
Sector Producer Manufacturing 2025 Sales Growth 2.998%
Fiscal Year-end 03 / 2026 Employees 2,660
View SEC Filings

ORGJF Valuation

P/E Current 15.591
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 12.361
Price to Sales Ratio 1.828
Price to Book Ratio 2.421
Price to Cash Flow Ratio 10.37
Enterprise Value to EBITDA 9.225
Enterprise Value to Sales 1.867
Total Debt to Enterprise Value 0.076

ORGJF Efficiency

Revenue/Employee 402,618.404
Income Per Employee 59,553.464
Receivables Turnover 1.342
Total Asset Turnover 0.854

ORGJF Liquidity

Current Ratio 2.552
Quick Ratio 2.202
Cash Ratio 0.26

ORGJF Profitability

Gross Margin 33.798
Operating Margin 19.061
Pretax Margin 19.819
Net Margin 14.792
Return on Assets 12.637
Return on Equity 21.374
Return on Total Capital 16.487
Return on Invested Capital 20.796

ORGJF Capital Structure

Total Debt to Total Equity 18.797
Total Debt to Total Capital 15.822
Total Debt to Total Assets 11.695
Long-Term Debt to Equity 3.07
Long-Term Debt to Total Capital 2.584
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Organo - ORGJF

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
997.30M 977.19M 1.04B 1.07B
Sales Growth
+5.10% -2.02% +6.41% +3.00%
Cost of Goods Sold (COGS) incl D&A
743.56M 719.09M 736.60M 709.00M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
11.85M 13.46M 13.90M 12.63M
Depreciation
- - - -
-
Amortization of Intangibles
- - - -
-
COGS Growth
+6.12% -3.29% +2.44% -3.75%
Gross Income
253.74M 258.10M 303.19M 361.97M
Gross Income Growth
+2.22% +1.72% +17.47% +19.39%
Gross Profit Margin
+25.44% +26.41% +29.16% +33.80%
2022 2023 2024 2025 5-year trend
SG&A Expense
157.17M 145.83M 147.28M 157.83M
Research & Development
19.10M 19.30M 19.56M 21.34M
Other SG&A
138.08M 126.54M 127.72M 136.49M
SGA Growth
-0.46% -7.21% +0.99% +7.16%
Other Operating Expense
- - - -
-
Unusual Expense
- - - 836.50K
-
EBIT after Unusual Expense
95.73M 112.27M 155.91M 204.14M
Non Operating Income/Expense
18.37M 7.25M 9.16M 9.73M
Non-Operating Interest Income
231.37K 258.27K 954.34K 787.14K
Equity in Earnings of Affiliates
1.42M 1.53M 1.40M 800.26K
Interest Expense
1.13M 1.17M 1.66M 1.61M
Interest Expense Growth
+2.45% +3.81% +41.46% -2.78%
Gross Interest Expense
1.13M 1.17M 1.66M 1.61M
Interest Capitalized
- - - -
-
Pretax Income
112.98M 118.32M 163.43M 212.25M
Pretax Income Growth
+23.59% +4.73% +38.12% +29.87%
Pretax Margin
+11.33% +12.11% +15.72% +19.82%
Income Tax
30.88M 31.51M 43.55M 53.60M
Income Tax - Current - Domestic
26.55M 34.15M 44.97M 53.18M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
4.32M (2.63M) (1.42M) 413.25K
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
1.42M 1.53M 1.40M 800.26K
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
82.10M 86.81M 119.87M 158.65M
Minority Interest Expense
133.48K 250.89K 165.97K 236.14K
Net Income
81.97M 86.56M 119.71M 158.41M
Net Income Growth
+22.89% +5.60% +38.30% +32.33%
Net Margin Growth
+8.22% +8.86% +11.51% +14.79%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
81.97M 86.56M 119.71M 158.41M
Preferred Dividends
- - - -
-
Net Income Available to Common
81.96M 86.56M 119.71M 158.41M
EPS (Basic)
1.7858 1.8873 2.6066 3.4461
EPS (Basic) Growth
+22.84% +5.68% +38.11% +32.21%
Basic Shares Outstanding
45.90M 45.86M 45.92M 45.97M
EPS (Diluted)
1.7858 1.8873 2.6066 3.4461
EPS (Diluted) Growth
+22.84% +5.68% +38.11% +32.21%
Diluted Shares Outstanding
45.90M 45.86M 45.92M 45.97M
EBITDA
108.42M 125.73M 169.81M 216.77M
EBITDA Growth
+6.54% +15.97% +35.06% +27.65%
EBITDA Margin
+10.87% +12.87% +16.33% +20.24%

Organo in the News